SEARCH

SEARCH BY CITATION

References

  • Adolfsson R., Gottfries C. G., Roos B. E. and Winblad B. (1979) Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br. J. Psychiatry 135, 216223.
  • del Amo E. M., Urtti A. and Yliperttula M. (2008) Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2. Eur. J. Pharm. Sci. 35, 161174.
  • Awasthi S., Hallene K. L., Fazio V., Singhal S. S., Cucullo L., Awasthi Y. C., Dini G. and Janigro D. (2005) RLIP76, a non-ABC transporter, and drug resistance in epilepsy. BMC Neurosci. 6, 61.
  • Berezowski V., Landry C., Dehouck M. P., Cecchelli R. and Fenart L. (2004) Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood-brain barrier. Brain Res. 1018, 19.
  • Breedveld P., Pluim D., Cipriani G., Wielinga P., van Tellingen O., Schinkel A. H. and Schellens J. H. (2005) The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients. Cancer Res. 65, 25772582.
  • Bronger H., Konig J., Kopplow K., Steiner H. H., Ahmadi R., Herold-Mende C., Keppler D. and Nies A. T. (2005) ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier. Cancer Res. 65, 1141911428.
  • Carl S. M., Lindley D. J., Couraud P. O., Weksler B. B., Romero I., Mowery S. A. and Knipp G. T. (2010) ABC and SLC transporter expression and pot substrate characterization across the human CMEC/D3 blood-brain barrier cell line. Mol. Pharm. 7, 10571068.
  • Choi T. B. and Pardridge W. M. (1986) Phenylalanine transport at the human blood–brain barrier. Studies with isolated human brain capillaries. J. Biol. Chem. 261, 65366541.
  • Cornford E. M. and Hyman S. (2005) Localization of brain endothelial luminal and abluminal transporters with immunogold electron microscopy. NeuroRx 2, 2743.
  • Dauchy S., Dutheil F., Weaver R. J., Chassoux F., Daumas-Duport C., Couraud P. O., Scherrmann J. M., De Waziers I. and Decleves X. (2008) ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J. Neurochem. 107, 15181528.
  • Dauchy S., Miller F., Couraud P. O., Weaver R. J., Weksler B., Romero I. A., Scherrmann J. M., De Waziers I. and Decleves X. (2009) Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells. Biochem. Pharmacol. 77, 897909.
  • Dyer J., Barker P. J. and Shirazi-Beechey S. P. (1997) Nutrient regulation of the intestinal Na+/glucose co-transporter (SGLT1) gene expression. Biochem. Biophys. Res. Commun. 230, 624629.
  • Enokizono J., Kusuhara H., Ose A., Schinkel A. H. and Sugiyama Y. (2008) Quantitative investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) in limiting brain and testis penetration of xenobiotic compounds. Drug Metab. Dispos. 36, 9951002.
  • Fernstrom J. D. and Wurtman R. J. (1972) Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 178, 414416.
  • Friden M., Winiwarter S., Jerndal G., Bengtsson O., Wan H., Bredberg U., Hammarlund-Udenaes M. and Antonsson M. (2009) Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids. J. Med. Chem. 52, 62336243.
  • Fukumoto H., Cheung B. S., Hyman B. T. and Irizarry M. C. (2002) Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch. Neurol. 59, 13811389.
  • Gao B., Hagenbuch B., Kullak-Ublick G. A., Benke D., Aguzzi A. and Meier P. J. (2000) Organic anion-transporting polypeptides mediate transport of opioid peptides across blood–brain barrier. J. Pharmacol. Exp. Ther. 294, 7379.
  • Gruetter R., Novotny E. J., Boulware S. D., Rothman D. L. and Shulman R. G. (1996) 1H NMR studies of glucose transport in the human brain. J. Cereb. Blood Flow Metab. 16, 427438.
  • Hawkins R. A., Huang S. C., Barrio J. R., Keen R. E., Feng D., Mazziotta J. C. and Phelps M. E. (1989) Estimation of local cerebral protein synthesis rates with L-[1-11C]leucine and PET: methods, model, and results in animals and humans. J. Cereb. Blood Flow Metab. 9, 446460.
  • Irifune M., Fukuda T., Nomoto M. et al. (1997) Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases. Brain Res. 763, 281284.
  • Ito K., Uchida Y., Ohtsuki S., Aizawa S., Kawakami H., Katsukura Y., Kamiie J. and Terasaki T. (2011) Quantitative membrane protein expression at the blood–brain barrier of adult and younger cynomolgus monkeys. J. Pharm. Sci. Epub ahead of print.
  • Izumi Y., Tokuda K., O’Dell K. A., Zorumski C. F. and Narahashi T. (2007) Neuroexcitatory actions of Tamiflu and its carboxylate metabolite. Neurosci. Lett. 426, 5458.
  • Kamiie J., Ohtsuki S., Iwase R. et al. (2008) Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria. Pharm. Res. 25, 14691483.
  • Kawakami H., Ohtsuki S., Kamiie J., Suzuki T., Abe T. and Terasaki T. (2011) Simultaneous absolute quantification of 11 cytochrome P450 isoforms in human liver microsomes by liquid chromatography tandem mass spectrometry with In silico target peptide selection. J. Pharm. Sci. 100, 341352.
  • Kis B., Isse T., Snipes J. A., Chen L., Yamashita H., Ueta Y. and Busija D. W. (2006) Effects of LPS stimulation on the expression of prostaglandin carriers in the cells of the blood–brain and blood–cerebrospinal fluid barriers. J. Appl. Physiol. 100, 13921399.
  • Koeppe R. A., Mangner T., Betz A. L., Shulkin B. L., Allen R., Kollros P., Kuhl D. E. and Agranoff B. W. (1990) Use of [11C]aminocyclohexanecarboxylate for the measurement of amino acid uptake and distribution volume in human brain. J. Cereb. Blood Flow Metab. 10, 727739.
  • Kusuhara H. and Sugiyama Y. (2009) In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney. Drug Metab. Pharmacokinet. 24, 3752.
  • Kusuhara H., Sekine T., Utsunomiya-Tate N., Tsuda M., Kojima R., Cha S. H., Sugiyama Y., Kanai Y. and Endou H. (1999) Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J. Biol. Chem. 274, 1367513680.
  • Lajtha A. (1974) In Aromatic Amino Acids in the Brain (WolstenholmeG. E. W. and FitzsimonsD. W., eds), pp. 2541. Elsevier, New York.
  • Langenfeld E., Zanger U. M., Jung K., Meyer H. E. and Marcus K. (2009) Mass spectrometry-based absolute quantification of microsomal cytochrome P450 2D6 in human liver. Proteomics 9, 23132323.
  • Leino R. L., Gerhart D. Z. and Drewes L. R. (1999) Monocarboxylate transporter (MCT1) abundance in brains of suckling and adult rats: a quantitative electron microscopic immunogold study. Brain Res. Dev. Brain Res. 113, 4754.
  • Leino R. L., Gerhart D. Z., Duelli R., Enerson B. E. and Drewes L. R. (2001) Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain. Neurochem. Int. 38, 519527.
  • Lescale-Matys L., Dyer J., Scott D., Freeman T. C., Wright E. M. and Shirazi-Beechey S. P. (1993) Regulation of the ovine intestinal Na+/glucose co-transporter (SGLT1) is dissociated from mRNA abundance. Biochem. J. 291(Pt 2), 435440.
  • Li N., Zhang Y., Hua F. and Lai Y. (2009) Absolute difference of hepatobiliary transporter multidrug resistance-associated protein (MRP2/Mrp2) in liver tissues and isolated hepatocytes from rat, dog, monkey, and human. Drug Metab. Dispos. 37, 6673.
  • Molina-Arcas M., Marce S., Villamor N. et al. (2005) Equilibrative nucleoside transporter-2 (hENT2) protein expression correlates with ex vivo sensitivity to fludarabine in chronic lymphocytic leukemia (CLL) cells. Leukemia 19, 6468.
  • Mori S., Takanaga H., Ohtsuki S., Deguchi T., Kang Y. S., Hosoya K. and Terasaki T. (2003) Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells. J. Cereb. Blood Flow Metab. 23, 432440.
  • Nakamichi H., Murakami M., Miura S., Kondoh Y., Mizusawa S. and Ono Y. (1993) L-[2-18F]Fluorophenylalanine and L-[U-14C]phenylalanine: a comparative study of their transport to rat brain. Nucl. Med. Biol. 20, 9599.
  • Nies A. T., Jedlitschky G., Konig J., Herold-Mende C., Steiner H. H., Schmitt H. P. and Keppler D. (2004) Expression and immunolocalization of the multidrug resistance proteins, MRP1–MRP6 (ABCC1–ABCC6), in human brain. Neuroscience 129, 349360.
  • Noh H. S., Lee H. P., Kim D. W., Kang S. S., Cho G. J., Rho J. M. and Choi W. S. (2004) A cDNA microarray analysis of gene expression profiles in rat hippocampus following a ketogenic diet. Brain Res. Mol. Brain Res. 129, 8087.
  • Ohtsuki S. and Terasaki T. (2007) Contribution of carrier-mediated transport systems to the blood–brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development. Pharm. Res. 24, 17451758.
  • Ohtsuki S., Yamaguchi H., Asashima T. and Terasaki T. (2007) Establishing a method to isolate rat brain capillary endothelial cells by magnetic cell sorting and dominant mRNA expression of multidrug resistance-associated protein 1 and 4 in highly purified rat brain capillary endothelial cells. Pharm. Res. 24, 688694.
  • Ose A., Ito M., Kusuhara H., Yamatsugu K., Kanai M., Shibasaki M., Hosokawa M., Schuetz J. D. and Sugiyama Y. (2009) Limited brain distribution of [3R,4R,5S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxyl ate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood–brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4). Drug Metab. Dispos. 37, 315321.
  • Pardridge W. M. (1983) Brain metabolism: a perspective from the blood–brain barrier. Physiol. Rev. 63, 14811535.
  • Pardridge W. M. and Oldendorf W. H. (1977) Transport of metabolic substrates through the blood–brain barrier. J. Neurochem. 28, 512.
  • Pardridge W. M., Yang J., Eisenberg J. and Tourtellotte W. W. (1987) Isolation of intact capillaries and capillary plasma membranes from frozen human brain. J. Neurosci. Res. 18, 352357.
  • Pellerin L., Pellegri G., Martin J. L. and Magistretti P. J. (1998) Expression of monocarboxylate transporter mRNAs in mouse brain: support for a distinct role of lactate as an energy substrate for the neonatal vs. adult brain. Proc. Natl. Acad. Sci. U S A 95, 39903995.
  • Philp N. J., Ochrietor J. D., Rudoy C., Muramatsu T. and Linser P. J. (2003) Loss of MCT1, MCT3, and MCT4 expression in the retinal pigment epithelium and neural retina of the 5A11/basigin-null mouse. Invest. Ophthalmol. Vis. Sci. 44, 13051311.
  • Pratt O. E. (1976) The transport of metabolizable substances into the living brain. Adv. Exp. Med. Biol. 69, 5575.
  • Sasongko L., Link J. M., Muzi M., Mankoff D. A., Yang X., Collier A. C., Shoner S. C. and Unadkat J. D. (2005) Imaging P-glycoprotein transport activity at the human blood–brain barrier with positron emission tomography. Clin. Pharmacol. Ther. 77, 503514.
  • Sharman D. F. (1966) Changes in the metabolism of 3,4-dihydroxyphenylethylamine (dopamine) in the striatum of the mouse induced by drugs. Br. J. Pharmacol. Chemother. 28, 153163.
  • Syvanen S., Lindhe O., Palner M., Kornum B. R., Rahman O., Langstrom B., Knudsen G. M. and Hammarlund-Udenaes M. (2009) Species differences in blood–brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport. Drug Metab. Dispos. 37, 635643.
  • Toovey S., Rayner C., Prinssen E. et al. (2008) Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review. Drug Saf. 31, 10971114.
  • Tsuruoka S., Ishibashi K., Yamamoto H., Wakaumi M., Suzuki M., Schwartz G. J., Imai M. and Fujimura A. (2002) Functional analysis of ABCA8, a new drug transporter. Biochem. Biophys. Res. Commun. 298, 4145.
  • Uchida Y., Kamiie J., Ohtsuki S. and Terasaki T. (2007) Multichannel liquid chromatography–tandem mass spectrometry cocktail method for comprehensive substrate characterization of multidrug resistance-associated protein 4 transporter. Pharm. Res. 24, 22812296.
  • Urquhart B. L. and Kim R. B. (2009) Blood–brain barrier transporters and response to CNS-active drugs. Eur. J. Clin. Pharmacol. 65, 10631070.
  • de Vries N. A. (2009) Preclinical models to study the impact of the blood-brain barrier in brain tumor chemotherapy. Doctor’s thesis, Division of Clinical Chemistry, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, the Netherlands.
  • Wen P. Y. and Kesari S. (2008) Malignant gliomas in adults. N. Engl. J. Med. 359, 492507.
  • Wiesel F. A., Blomqvist G., Halldin C., Sjogren I., Bjerkenstedt L., Venizelos N. and Hagenfeldt L. (1991) The transport of tyrosine into the human brain as determined with L-[1-11C]tyrosine and PET. J. Nucl. Med. 32, 20432049.
  • Young L. T., Warsh J. J., Kish S. J., Shannak K. and Hornykeiwicz O. (1994) Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder. Biol. Psychiatry 35, 121127.